Welcome Notes

Dear Esteemed Attendees, Researchers, and Colleagues,

It is with great enthusiasm that we welcome you to the 19th International Conference on Obesity Medicine taking place in the historic and dynamic city of London, UK, on October 06-07, 2025. This prestigious gathering provides a unique platform where leading minds from around the world come together to share knowledge, advancements, and innovative research in the critical field of obesity medicine.

This year, our conference theme, “AI in Obesity Diagnosis and Early Intervention,” highlights the transformative role of artificial intelligence in reshaping the landscape of obesity care. Over the course of these two days, we will explore how cutting-edge technologies are driving early detection, enhancing treatment strategies, and improving patient outcomes.

We encourage your active participation—ask questions, share your insights, and connect with fellow attendees. Your involvement is what makes this conference a thriving hub of discovery and progress. Thank you for joining us in this vital endeavour. Together, let’s advance the future of obesity medicine for healthier communities worldwide.

About Obesity Medicine

Welcome to the 19th International Conference on Obesity Medicine
October 06–07, 2025 | London, UK
Theme: AI in Obesity Diagnosis and Early Intervention

We are pleased to welcome you to the 19th International Conference on Obesity Medicine, taking place in the historic and vibrant city of London, UK, on October 6–7, 2025. This premier event is dedicated to addressing the complex and evolving challenges of obesity and its medical management, with a special focus this year on the transformative role of artificial intelligence in diagnosis and early intervention.

As obesity rates continue to rise globally, the importance of innovation in prevention, diagnosis, and treatment has never been more critical. Obesity medicine is at the forefront of improving public health, and this conference serves as a vital platform for researchers, clinicians, and academics to share insights, explore new technologies, and foster multidisciplinary collaboration.

Over the course of two days, attendees will engage in discussions on cutting-edge research, AI-driven healthcare solutions, and evidence-based clinical practices. Our dynamic program features keynote addresses, expert-led workshops, and interactive sessions designed to inspire dialogue and drive progress.

We invite you to join us on this exciting journey of exploration and knowledge exchange as we work together to shape the future of obesity medicine and enhance global health outcomes through innovation and collaboration.

Session & Tracks

Track 1 : Clinical Obesity
Track 2: Obesity Causes
Track 3: Obesity Prevention
Track 4: Obesity in Women
Track 5: Obesity and Weight Loss
Track 6 : Obesity & Associated Health Disorders
Track 7: Obesity and Weight Management
Track 8: Current Research on Obesity
Track 9 : Obesity & Cancer
Track 10: Advanced Treatment for Obesity
Track 11: Obesity and Chronic Diseases
Track 12: Obesity and Cardiovascular Diseases
Track 13: Anti-Obesity Drugs
Track 14: Dietary and Lifestyle Changes
Track 15 : Obesity and Metabolic Diseases
Track 16: Bariatric Surgery
Track 17: Gynaecology & Obstetrics
Track 18: Non-Surgical Treatment for Obesity
Track 19: Diabetes, Endocrinology and Obesity
Track 20: Childhood Obesity and Nutrition
Track 21: Obesity and Eating Disorder
Track 22 : Diet & Nutrition
Track 23: Physical activity; Exercise & Kinesiology
Track 24: Yoga and Naturopathy
Track 25: Liposuction and Weight Loss Treatments
Track 26: Role of Steroids and Hormones in Obesity
Track 27: Genetics and Epigenetics of Obesity
Track 28: Hyperalimentation and Obesity

TARGET AUDIENCE

• Obesity Specialists and Bariatric Physicians
• Endocrinologists
•  Primary Care Physicians
•  Dietitians and Nutritionists
•  Bariatric Surgeons
•  Public Health Experts
•  Researchers and Academics
• Exercise and Fitness Specialists
• Psychologists and Behavioural Therapists
•  Pharmacologists and Drug Developers
•  Healthcare Administrators and Policymakers
• Nurses and Nurse Practitioners
•  Medical Students and Trainees
•  Healthcare Technology and Device Developers
• Pharmaceutical Industry Representatives

Reason to Attend

• Why You Should Attend:

  1. Publication Opportunities
  Accepted abstracts will be published in a renowned medical journal with DOI assignment—enhancing the visibility, credibility, and global impact of your research.

  2. Foster Global Collaboration
  Engage in a truly international forum that encourages the exchange of groundbreaking ideas, multidisciplinary partnerships, and collaborative research initiatives.

  3. Exclusive Sponsorship & Exhibition
  Highlight your innovations, services, and solutions to a global audience of key stakeholders through tailored sponsorship and exhibition opportunities.

  4. Stay Ahead of the Curve
  Gain first-hand access to emerging research, technological advances, and AI applications reshaping the future of obesity medicine.

  5. Sharpen Your Skills
  Present your work to a distinguished audience and receive insightful feedback from leading experts in the field—an invaluable experience for both early-career and seasoned professionals.

  6. Build Your Network
  Connect with top researchers, clinicians, policymakers, and innovators from across the globe—expanding your professional network and future collaborations.

  7. Boost Your Visibility
  Enhance your professional standing and increase recognition within the obesity medicine community through active participation and exposure.

  8. Share and Inspire
  Showcase your findings, inspire new thinking, and spark impactful discussions with fellow experts in obesity research and clinical care.

  9. Stay Informed and Inspired
  Stay updated on pressing challenges, AI-driven innovations, and best practices that are shaping the trajectory of obesity prevention and treatment.

  10. Drive Innovation in Healthcare
  Contribute to conversations that accelerate progress and promote pioneering approaches to tackling obesity in the digital age.

  Join us in London for two days of insightful dialogue, expert presentations, and unparalleled networking. Together, let’s lead the transformation of obesity medicine through data-driven strategies, innovation, and global cooperation.

MARKET OVERVIEW

This market analysis will explore the various facets of the obesity medicine market, focusing on drug development, medical equipment, industry trends, management strategies, the pharmaceutical industry’s involvement, and hospital treatments.

The obesity medicine market encompasses a broad spectrum of solutions that target obesity prevention, management, and treatment. It includes the pharmaceutical sector, medical device companies, surgical solutions, and lifestyle intervention programs.

Obesity management requires a multidisciplinary approach, which combines behavioural therapy, lifestyle changes, medications, and surgical interventions. Increasing awareness of obesity-related health issues and the introduction of government initiatives and programs to address obesity have contributed to the growth of this market.

Key Market Drivers:

Rising global obesity prevalence.
Increasing awareness of the health risks associated with obesity.
Technological advancements in surgical equipment and minimally invasive procedures.
Government initiatives to address obesity through health programs.
Innovation in drug development for long-term obesity management.

Market Restraints:

High costs of obesity treatment, particularly for surgical procedures.
Social stigma surrounding obesity, which may prevent patients from seeking treatment.
Safety and efficacy concerns regarding long-term use of anti-obesity medications. (Read More)

PAST CONFERENCE REPORT

“The 18th International Conference on Obesity Medicine” was held in the vibrant city of “Toronto,Canada" on “May 12-13, 2025 " bringing together an impressive array of professionals from various fields within obesity medicine and healthcare. This two-day event provided a comprehensive platform for advancing knowledge and innovation in obesity research, treatment, and prevention.

Key Highlights

• Expert-Led Keynotes: Renowned researchers and clinicians shared groundbreaking insights on obesity treatment, management, and the broader impact of obesity on global health. Key topics included metabolic pathways in obesity, emerging pharmacological therapies, and personalized treatment approaches.
• Scientific Sessions and Symposiums: Attendees participated in focused sessions addressing childhood obesity, comorbidities, lifestyle interventions, and advancements in bariatric surgery. Each session offered in-depth discussions on the challenges and future directions in obesity research and treatment.
• Poster Presentations and Young Researcher Forum: An impressive array of posters showcased innovative research projects, providing a valuable platform for emerging researchers to share their findings. The Young Researcher Forum enabled early-career scientists to present their work and receive valuable feedback from experts.
• Workshops and Interactive Panels: Workshops focused on practical applications and hands-on techniques, from lifestyle coaching and behavioural interventions to advancements in medical devices for obesity management. Interactive panels offered opportunities for audience engagement and real-time feedback from leaders in the field.
• Networking and B2B Opportunities: Dedicated networking sessions fostered collaboration, allowing attendees to establish partnerships and connect with like-minded professionals. Business-to-business (B2B) meetings also provided a setting for industry leaders and innovators to showcase their products and services.
• Exhibitions and Sponsorship Opportunities: The event hosted an exhibition where companies showcased the latest developments in nutritional products, health tech, and obesity-related treatments. Sponsors gained extensive visibility and the opportunity to connect with a targeted international audience.

The 18th International Conference on Obesity Medicine in  Toronto,Canada was a significant success, creating a collaborative environment for professionals to discuss critical challenges and explore new directions in obesity care and research. Attendees left the conference with enhanced knowledge, enriched connections, and new ideas to implement within their practices and research initiatives.

Important Guidelines:

Abstract submission deadline: August 28, 2025

First Phase Registration: June 28, 2025

Early Bird Registration Deadline: May 28, 2025

Book your slot: Obesity Medicine 2025.

Email: Program Manager at obesitymedicine@speakermeeting.com

WhatsApp at 443308221359 with details of the 5 participants.

Abstract submission guidelines for Obesity Medicine 2025:

If you choose to participate in this conference, you need to submit an abstract.
The abstract should carry the summary of a research.
Abstract should be submitted either through e-mail or using the link given below.
Abstracts should be based on any areas as listed in this website as sessions/tracks.

Note: The review process for the submitted abstract will take 2-3 working days.

Submitting abstract will be published in conference proceedings in the conference supporting journal

Abstract Submission website: Obesity Medicine Abstract Submission  

Contact us:
Event Manager| Obesity Medicine 2025
Email Id:  contact@speakermeeting.com